Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02768701
Title Study Of Single-dose Cyclophosphamide +Pembrolizumab In Patients With Metastatic Triple Negative Breast Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors UNC Lineberger Comprehensive Cancer Center

triple-receptor negative breast cancer


Cyclophosphamide + Pembrolizumab

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
George Washington University-Medical Faculty Associates Washington District of Columbia 20037 United States Details
Lineberger Comprehensive Cancer Center Chapel Hill North Carolina 27599 United States Details
Cone Health Cancer Center Greensboro North Carolina 27403 United States Details
Rex Cancer Center Raleigh North Carolina 27607 United States Details
University of Pittsburgh Medical Center Pittsburgh Pennsylvania 15213 United States Details
*Shaded cells indicate that there was no data available from for the field